We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
-0.18%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5.34B
AUM Growth
-$237M
Cap. Flow
-$130M
Cap. Flow %
-2.43%
Top 10 Hldgs %
17.36%
Holding
1,615
New
114
Increased
629
Reduced
604
Closed
130

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$17.6M
2
AAPL icon
Apple
AAPL
+$16.6M
3
NVDA icon
NVIDIA
NVDA
+$14.2M
4
IDXX icon
Idexx Laboratories
IDXX
+$13.7M
5
XPO icon
XPO
XPO
+$13.2M

Sector Composition

Rank Sector Weight
1 Technology 18.05%
2 Financials 11.09%
3 Healthcare 10.47%
4 Consumer Discretionary 9.45%
5 Industrials 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VUZI icon
1251
Vuzix
VUZI
$194M
$284K 0.01%
27,220
+5,528
+25% +$73.9K
WIA
1252
Western Asset Inflation-Linked Income Fund
WIA
$185M
$284K 0.01%
20,600
CLB icon
1253
Core Laboratories
CLB
$477M
$282K 0.01%
10,177
-20
-0.2% -$609
PII icon
1254
Polaris
PII
$3.88B
$282K 0.01%
2,355
+363
+18% +$46.1K
U icon
1255
Unity
U
$14.6B
$282K 0.01%
+2,228
New +$264K
VONG icon
1256
Vanguard Russell 1000 Growth ETF
VONG
$42.5B
$282K 0.01%
4,000
XMMO icon
1257
Invesco S&P MidCap Momentum ETF
XMMO
$7.09B
$282K 0.01%
3,348
-152
-4% -$13K
OZK icon
1258
Bank OZK
OZK
$5.57B
$280K 0.01%
6,515
VWOB icon
1259
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$280K 0.01%
+3,580
New +$285K
CET
1260
Central Securities Corp
CET
$1.54B
$278K 0.01%
6,590
IXN icon
1261
iShares Global Tech ETF
IXN
$8.34B
$278K 0.01%
4,919
-31
-0.6% -$1.81K
GWRE icon
1262
Guidewire Software
GWRE
$12.8B
$276K 0.01%
2,324
-44
-2% -$5.08K
PGF icon
1263
Invesco Financial Preferred ETF
PGF
$676M
$273K 0.01%
14,401
-309
-2% -$5.9K
AFT
1264
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$273K 0.01%
17,270
+1,973
+13% +$31K
S icon
1265
SentinelOne
S
$6.31B
$272K 0.01%
+5,080
New +$279K
AVUV icon
1266
Avantis US Small Cap Value ETF
AVUV
$30.3B
$270K 0.01%
3,576
AMN icon
1267
AMN Healthcare
AMN
$1.35B
$269K 0.01%
+2,341
New +$248K
PIZ icon
1268
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$719M
$268K 0.01%
7,051
-26
-0.4% -$1.04K
VSXY
1269
Victoria's Secret
VSXY
$7.01B
$267K 0.01%
+4,827
New +$293K
CRNC icon
1270
Cerence
CRNC
$375M
$266K 0.01%
2,770
+389
+16% +$42.5K
DBO icon
1271
Invesco DB Oil Fund
DBO
$396M
$265K 0.01%
19,305
+99
+0.5% +$1.26K
XHE icon
1272
State Street SPDR S&P Health Care Equipment ETF
XHE
$163M
$264K ﹤0.01%
2,106
-115
-5% -$14.7K
BSCN
1273
DELISTED
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
$263K ﹤0.01%
+12,156
New +$264K
IYF icon
1274
iShares US Financials ETF
IYF
$4.67B
$262K ﹤0.01%
3,168
RSKD icon
1275
Riskified
RSKD
$701M
$262K ﹤0.01%
+11,473
New +$322K

Similar funds

Oppenheimer & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Oppenheimer & Co held 1,615 positions worth $5.34B, down 4.2% from $5.58B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q3 2021 filing shows 114 new, 629 increased, 604 reduced and 130 closed positions. Its largest new stake was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K. The largest sale was Microsoft, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q3 2021 buy was Global X S&P 500 Covered Call ETF: 1,004,600 shares worth $488K.
  • Oppenheimer & Co added most to Invesco Ultra Short Duration ETF in Q3 2021, an estimated $9.29M increase.
  • Oppenheimer & Co's biggest Q3 2021 reduction was Microsoft, cutting an estimated $17.6M.
  • Oppenheimer & Co fully exited Pricesmart in Q3 2021, selling an estimated $6.18M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $5.34B portfolio in Q3 2021.
  • Oppenheimer & Co opened 114 new positions and closed 130 in Q3 2021.
  • Oppenheimer & Co's portfolio value fell 4.2% quarter-over-quarter to $5.34B.

Based on Oppenheimer & Co's 13F filing for Q3 2021, filed 12 Nov 2021.